Welcome to our dedicated page for INVESTORS TITLE CO SEC filings (Ticker: ITIC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on INVESTORS TITLE CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into INVESTORS TITLE CO's regulatory disclosures and financial reporting.
INVESTORS TITLE CO (ITIC) director Tammy Coley reported only acquisition-type transactions on August 27, 2026. She exercised three tranches of Stock Appreciation Rights covering a total of 363 shares of common stock, with exercise prices of $160.94, $246.75, and $238.06 per share, and received matching grants of 363 common shares. No sales or dispositions were reported in this filing.
Investors Title Co director Richard M. Hutson II reported a grant or award of 212 shares of Common Stock on 2026-08-12 at a value of $122.80 per share. Following this compensation-related acquisition, his directly held position increased to 4,898 shares of Investors Title Co common stock.
Investors Title Company reported stronger results for the three and six months ended June 30, 2026. Six‑month total revenues were $150.5 million, up from $130.2 million, driven largely by title operations, which contributed 92.0% of revenues. Net premiums written rose 23.9% in the quarter and 17.5% year‑to‑date, reflecting higher real estate activity and ongoing expansion.
Six‑month net income increased to $20.7 million from $15.4 million, with after‑tax profit margins improving to 13.8% from 11.9%. Net investment gains climbed sharply to $5.3 million from $0.9 million, aided by higher equity valuations, while interest and dividend income softened on lower average yields. Non‑title services revenue declined slightly on weaker like‑kind exchange activity. The loss ratio rose to 2.7% for the six‑month period (from 2.4%), and the reserve for claims grew modestly to $39.1 million. The company remains debt‑free, with total assets of $380.1 million, stockholders’ equity of $286.6 million, and positive operating cash flow of $9.8 million for the first half of 2026.
Investors Title Company reported strong results for the quarter ended June 30, 2026. Net income was $14.6 million, or $7.73 per diluted share, up from $12.3 million, or $6.48, in the prior-year quarter. Revenues increased 17.5% to $86.5 million, driven by higher net premiums written, escrow and other title-related fees, and net investment gains.
Operating expenses rose 15.9% to $67.1 million, mainly from higher agent commissions, personnel costs, and a larger provision for claims. Income before income taxes was $19.4 million, while adjusted income before income taxes (non-GAAP) was $14.7 million. For the first six months of 2026, net income reached $20.7 million on revenues of $150.5 million, and management characterized the quarter as its strongest financial performance in several years.
Investors Title Co director Tammy Coley received a grant of 750 Stock Appreciation Rights tied to an equal number of common shares. The rights have an exercise price of $238.06 per share, become exercisable on June 30, 2026, and expire on May 20, 2033. This is a compensation-related award, not an open-market stock purchase or sale.
INVESTORS TITLE CO director receives stock-based award. Director Joseph B. Dempster Jr. was granted 750 Stock Appreciation Rights on May 20, 2026. Each right is tied to one share of common stock with a conversion price of $238.06 per share and expires on May 20, 2033.
Hutson Richard M II reported acquisition or exercise transactions in this Form 4 filing.
Investors Title Co director Richard M. Hutson II received a grant of stock-based compensation. On May 20, 2026, he was awarded 750 Stock Appreciation Rights, each tied to one share of common stock with a base price of $238.06. These rights become exercisable on June 30, 2026 and expire on May 20, 2033. This is a compensation award, not an open-market stock purchase or sale.
Investors Title Co director Elton C. Parker Jr. received a grant of Stock Appreciation Rights tied to the company’s common stock. The award covers 750 underlying shares at an exercise price of $238.06 per share and is scheduled to expire on May 20, 2033. This is a compensation-related, non-market transaction with no open-market buying or selling reported.
Investors Title Co director James E. Scott received a grant of 750 Stock Appreciation Rights on May 20, 2026. Each right is tied to one share of common stock with an exercise price of $238.06, first exercisable on June 30, 2026, and expiring on May 20, 2033.
Investors Title Co director James H. Speed Jr. received a grant of 750 stock appreciation rights tied to the company’s common stock. These rights have an exercise price of $238.06 per share and are scheduled to become exercisable on June 30, 2026, expiring on May 20, 2033.
This is a compensation-related award rather than an open-market trade, so it does not reflect a buy or sell decision in the company’s stock.